Peptide Decoding
New?New to peptides?Start here →
Decoding

Semaglutide_Dosage, benefits & legal status

Also known as Ozempic, Wegovy, Rybelsus, GLP-1 SM, GLP-1 S, GLP-1 (S), sema, EZP-1P, GLP-1 SG, EP-1 S

Published July 22, 2026 · Updated August 24, 2026

The drug in Ozempic and Wegovy: a weekly shot that curbs hunger for steady weight loss.

Weight lossGLP-1 agonistFDA-approved
Common vial size5 mg
Dose0.25 up to 2.4 mg per week (start low, increase slowly)
FrequencyWeekly
RouteUnder the skin (also comes as a pill)
StatusFDA-approved
CycledNot cycled

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

01

What is Semaglutide?

Plain language first. The technical label stays, but it never stands alone.

Overview

It flips on your 'I'm full' signal, so you feel satisfied sooner, eat less, and your blood sugar steadies. It is the active drug in Ozempic and Wegovy.

The technical version

Semaglutide is a GLP-1 receptor agonist, a lab-made copy of a natural gut hormone your body releases after eating.

What it's used for

People use it to lose weight and steady their blood sugar. It calms appetite and cravings so you feel full sooner and eat less without white-knuckling it.

02

How does Semaglutide work?

What it does in the body, and where.

Semaglutide copies a single gut hormone, GLP-1. That one target is enough to change how hungry you feel, how fast your stomach empties, and how your body handles sugar after a meal.

  1. 01
    It docks at the GLP-1 receptor
    The same receptor your own gut hormone uses after you eat, so your body reads it as an ordinary fullness signal.
  2. 02
    Your stomach empties more slowly
    Food sits longer, so you stay full for longer. This is also where most of the nausea comes from.
  3. 03
    Appetite signalling in the brain quiets down
    Cravings and food noise drop, which is what most people notice first and miss most when they stop.
Receptors
HITSGLP-11

Acts on one receptor.

03

What else is it used for?

Each group carries its own evidence level.

Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

Weight loss

FDA-approved
  • Human trialIn a 68-week trial, average weight loss was 14.9% of body weight versus 2.4% on a dummy injection.
  • Human trial86.4% of people lost at least 5% of their body weight, against 31.5% on placebo.
  • Human trial34.8% lost at least a fifth of their body weight, against 2.0% on placebo.
  • Human trialIn the follow-up, people who had lost 17.3% regained 11.6 percentage points within a year of stopping, leaving a net loss of 5.6%. Most of the weight comes back if you stop.

Diabetes and heart health

FDA-approved
  • Human trialIn people who already had type 2 diabetes, average weight loss was 9.6% versus 3.4% on placebo, so it works but somewhat less well.
  • RegulatoryApproved as Ozempic in 2017 for type 2 diabetes and as Wegovy in 2021 for weight management.
Often left out

Trial weight-loss figures are often quoted without the follow-up: people regained most of the weight within a year of stopping.

The published record

Research index

6,371

Records indexed for Semaglutide400 papers and 100 trials indexed in detail.

261 in humans, 127 of them original studies.

754 registered trials, 18 with posted results among the 100 indexed.

FDA: Named as an unapproved new drug.

Browse the records

In animalsPro
In the labPro
ReviewsPro
Senior author sharePro

Counted from Europe PMC indexing, not read by a person. Human means indexed under humans, which includes reviews and work on human cells. Original studies exclude reviews and lab work on human cells.Last updated 11 September 2026.

Semaglutide vial rendering
Compound field notes

At a glance

Four things to know about Semaglutide

01

Evidence

FDA-approved

02

Category

Weight loss and metabolic

03

Common vial

5 mg

04

Half-life

About 1 week

04

How much, and do you cycle it?

The range, and whether you take breaks.

0.25 up to 2.4 mg per week (start low, increase slowly), weekly. Not cycledHuman study

Taken continuously, with the dose stepped up rather than paused. In the STEP 1 extension people regained about two thirds of the weight they had lost within a year of stopping. The question is whether to stay on it, not when to take a break.

Source: Wilding et al., STEP 1 extension: weight regain after semaglutide withdrawal (Diabetes Obes Metab 2022)

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

About 1 weekFDA label

The label states approximately 1 week, and that semaglutide is present in the circulation for about 5 weeks after the last dose.

Source: Ozempic (semaglutide) US prescribing information, section 12.3. DailyMed setid adec4fd2-6858-4c99-91d4-531f5f2a2d79

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Printed on the vial.
What you paid per vial
$
Used for cost per dose only.
Your dose (mg)
Commonly referenced range: 0.25 up to 2.4 mg per week (start low, increase slowly)FDA label

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

Your draw

10 / 100 units
What it costs

Semaglutide starts at $10.00 across 45 vendors, typically $3.20 – $21.40 per mg.

100 listings, last read Sep 5, 2026. Shipping and card fees are not included.

See all 100 listings →
07

How do you store it?

Before mixing, and after.

Fridge before first use. Room temperature is fine once in use.

Sealed pens live in the fridge. Once you start a pen it can stay at room temperature for the in-use window on the label (often about 4 to 6 weeks depending on the product). Keep it out of light, do not freeze it, and toss it if it has been frozen or left hot.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.
Handling note

Vials sold as "GLP-1 SM" or "GLP-1 (S)" are semaglutide. GLP-1 on its own is a hormone and a whole class of drugs, so the bare term does not identify what is in a vial. Check the label for semaglutide.

Who should avoid it

Check these before anything else.
  • A personal or family history of medullary thyroid cancer, or the genetic condition MEN 2
  • Pregnancy, or trying to become pregnant
  • A history of pancreatitis, which needs a conversation with your doctor first
  • Severe stomach-emptying problems (gastroparesis)

Stop and get help

These are emergencies. Seek care.
  • Severe stomach pain that spreads to your back, which can signal pancreas inflammation
  • A lump or swelling in your neck, hoarseness, or trouble swallowing
  • Vomiting badly enough that you cannot keep fluids down
  • Sudden changes in your vision
  • Signs of an allergic reaction such as face or throat swelling or trouble breathing

Common effects

Expected, and usually mild.
  • Nausea, which is the most common effect and usually worst in the first weeks and after each dose increase
  • Diarrhea, constipation, and vomiting
  • Tiredness, which real-world users report far more often than trial write-ups suggest
  • Burping and reflux
  • Injection-site redness

What regulators say

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Semaglutide approved?

And where the numbers on this page come from.

Yes. Semaglutide is FDA approved and available on prescription in the United States.

  • Approval status
    FDA-approved
  • Route
    Under the skin (also comes as a pill)
  • Checked
    August 2026

What has happened recently

In January 2026 the FDA asked that the warning about suicidal thoughts and behaviour be removed from the obesity versions of this drug family after a review found no increased risk. Labels were updated in February 2026.

You can compare this against the whole library, or read how to check a seller.


Guides for this compound

Sources

Last reviewed 14 August 2026

Beyond these, 500 records are indexed. Browse the records